These final results, along with a prior report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the thought of focusing on ACKR3 as a novel technique to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Ailments. At times I receive https://billv950rjz6.blogpixi.com/profile